Items Tagged ‘News’

December 14th, 2017

What to Tell Children when Facing a Diagnosis of Cancer

By

If you have children in your life, you already know that they tend to be creatures of habit who rely on their daily routine. There may be unexpected changes in their routine with your fight against cancer, and you may be concerned about the best way to talk to them about it. Whether you’re a […]

View full entry

Tags: cancer, children, General, News


December 14th, 2017

Acupuncture Reduces Aromatase Inhibitor Joint Pain in Women with Breast Cancer

By

According to a well designed study presented at the 2017 San Antonio Breast Cancer Symposium acupuncture is effective in reducing pain and stiffness associated with aromatase inhibitor (AI) therapy in women with early-stage breast cancer.1 Stiffness and joint pain is a well documented concern of women undergoing AI therapy for the treatment and prevention of […]

View full entry

Tags: Acupuncture, Aromatase, Arthralgia, Arthritis, Breast Cancer, Complementary Alternative Medicine, inhibitor, joint pain, News


December 13th, 2017

Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer

By

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. Doctors who specialize in treating cancers with radiation are known as radiation oncologists. During radiation therapy, high-energy x-rays are used to kill cancer cells. Radiation therapy can be given by a machine that aims x-rays at the body (external beam radiation) or by […]

View full entry

Tags: Cervical Cancer, News, radiation therapy


December 13th, 2017

Addition of Darzalex™ Improves Outcomes in Newly Diagnosed Multiple Myeloma

By

The addition of Darzalex (daratumumab) to the standard treatment combination consisting of Velcade (bortezomib), melphalan, and prednisone (VMP) reduces disease progression or death by 50%, among patients with newly diagnosed multiple myeloma who are not eligible to undergo a stem cell transplant. These results were presented as a late-breaking abstract at the 2017 annual meeting […]

View full entry

Tags: bortezomib, daratumumab, Darzalex, melphalan, Multiple Myeloma, News, Precision Cancer Medicine, prednisone, velcade, VMP


December 13th, 2017

Mogamulizumab Superior to Vorinostat in Cutaneous T Cell Lymphoma

By

Results were recently presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta from a international comparative clinical trail evaluating mogamulizumab in patients with previously treated cutaneous T-cell lymphoma (CTCL). Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in a cancer’s genome. Once a […]

View full entry

Tags: American Society of Hematology, ASH, Cutaneous T Cell Lymphoma, Mogamulizumab Vorinostat, News, non-hodgkin lymphoma, Non-Hodgkin's Lymphoma, Precision Cancer Medicine, T-Cell Non-Hodgkin's Lymphoma, targeted therapy


December 12th, 2017

Kisqali® Improves Outcomes of Premenopausal Women with HR+/HER2- Advanced Breast Cancer

By

It was announced today that results from the Phase III MONALEESA-7 trial evaluating Kisqali® (ribociclib) in combination endocrine-based therapy in premenopausal or perimenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer will be presented as a late-breaking oral presentation at the 2017 Annual San Antonio Breast Cancer […]

View full entry

Tags: advanced breast cancer, Breast Cancer, cyclin-dependent kinase, inhibitor, kisqali, MONELESSA 7, News, Precision Cancer Medicine, premenopausal, ribociclib, San Antonio Breast Cancer Symposium


December 12th, 2017

Keytruda Immunotherapy Shows Promise for Patients With Herceptin-resistant Breast Cancer

By

A combination of Keytruda (pembrolizumab) and Herceptin (trastuzumab), tested in patients with Herceptin-resistant advanced HER2-positive breast cancer, was well tolerated and had clinical benefit in patients whose tumors were positive for a biomarker for Keytruda, according to data presented at the 2017 San Antonio Breast Cancer Symposium. About HER2-Positive Breast Cancer About one in five […]

View full entry

Tags: Breast Cancer, Herceptin-resistant, immunotherapy, keytruda, News, pembrolizumab, Precision Cancer Medicine, SABCS, trastuzumab


December 7th, 2017

FDA and CMS Collaborate to Make Novel Cancer Biomarker Test Available

By

The U.S. Food and Drug Administration (FDA) has approved the F1CDx biomarker test designed to detect mutations in 324 genes and two genomic signatures in cancer patients. In a truly collaborative effort between the FDA and The Centers for Medicare & Medicaid Services (CMS) the latter proposed coverage of the F1CDx test under the new […]

View full entry

Tags: biomarker testing, CMS, foundation medicine, General, genomic testing, immunotherapy, KEYNOTE-028, News, Other News Topics (not Types of Cancer), PD-L1 positive, Precision Cancer Medicine, SCLS


December 7th, 2017

Managment of the Side Effects of Radiation for Cervical Cancer

By

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. With any treatment of cancer you must first understand your responsibility and your medical team’s role as well as explore treatment options and get a second opinion(s) before you begin treatment. Since the side effects of radiation can be significant, talk to your […]

View full entry

Tags: Cervical Cancer, News, radiation therapy


December 6th, 2017

Fedratinib May Represent New Option for Jakafi-Resistant Myelofibrosis

By

Patients with myelofibrosis resistant or intolerant to Jakafi (ruxolitinib) may have an alternative treatment option with a novel JAK2-selective inhibitor fedratinib, according to the results of clinical study recently published in the medical journal Lancet.1 About Myelofibrosis Myelofibrosis is a type of blood cancer known as a myeloproliferative neoplasm that is chronic and progressive in […]

View full entry

Tags: essential thrombocytosis, fedratinib, jakafi, mpn, myelofibrosis, myeloproliferative neoplasm, Myeloproliferative Neoplasms MPN, News, polycythemia vera, ruxolitinib


December 6th, 2017

The Role of Immunotherapy in the Treatment of Advanced Non Small Cell Lung Cancer

By

Treatment options for advanced NSCLC fit into 3 main categories… Targeted Therapy – we test lung cancer for specific mutations to see if we have an appropriate targeted medication. Immunotherapy – if targeted therapy is not an option immunotherapy should be part of the initial treatment strategy. We test the cancer for a specific protein […]

View full entry

Tags: keytruda, lung biomarker, Lung Cancer, Lung Cancer - Non-Small Cell, lung cancer treatment, News, non-small cell lung cancer, Precision Cancer Medicine


December 6th, 2017

What You Should Know About the Side Effects of Surgery for Cervical Cancer

By

A hysterectomy is a common surgical treatment of early stage cancer and precancerous disease of the cervix in women. With any treatment of cancer it is important to first understand your responsibility and your medical team’s role as well as explore treatment options and get a second opinion(s) before you begin treatment. Since the side […]

View full entry

Tags: Cervical Cancer, News, surgery


December 1st, 2017

Diagnosed with Esophageal Cancer: 10 Tips on How to Get The Most From Your Doctor

By

1) Choose Your Doctor Carefully Surgeons, medical oncologists and radiation oncologists are the primary doctors involved with esophageal cancer and often work in collaboration. Pick your primary oncologist carefully, rely on people you trust including nurses and other health care professionals who make help with recommendations.  Make sure your doctor is someone you feel comfortable […]

View full entry

Tags: Esophageal Cancer, News


December 1st, 2017

Understanding Low Back Pain

By

From theSpineCommunity Back pain is a symptom associated with over 60 different medical conditions.  These disorders involve a number of different organ systems.  A variety of healthcare professionals have expertise that can be useful in the diagnosis and treatment of these illnesses.  The following list contains a list of some of those professionals who can […]

View full entry

Tags: General, Health and Wellness, News


November 22nd, 2017

Incyte Announces Initiation of Clinical Trial Evaluating Jakafi® for the Treatment of Essential Thrombocythemia

By

Incyte Corporation announced that the first patient has been treated in the RESET pivotal trial evaluating Jakafi®  (ruxolitinib) compared to anagrelide for the treatment of patients with essential thrombocythemia (ET) who are resistant to or intolerant of hydroxyurea (HU). “We are pleased to treat the first patient in our pivotal trial evaluating ruxolitinib as a […]

View full entry

Tags: essential thrombocythemia, ET, Incyte Corporation, jakafi, Myeloproliferative Neoplasms MPN, News, RESET Clinical Trial, ruxolitinib